Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

P21 Real vs Fake: Visual and Lab Comparison

Lyophilised appearance Compact white-to-off-white cake, evenly distributed at vial bottom Scattered powder, chalky residue on vial walls, or friable dust-like texture Visual inspection under bright light Authentic lyophilisation produces a cohesive cake; scatt

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Lyophilised appearance
  • Compact white-to-off-white cake, evenly distributed at vial bottom
  • Scattered powder, chalky residue on vial walls, or friable dust-like texture
  • Visual inspection under bright light
  • Authentic lyophilisation produces a cohesive cake; scattered powder indicates improper freeze-drying or no vacuum process
  • Reconstitution behaviour
  • Dissolves completely in 60–90 seconds, crystal-clear colourless solution, no particles
  • Cloudiness, precipitate formation, gelatinous clumps, or incomplete dissolution
  • Add 1mL bacteriostatic water, observe without shaking
  • Cloudiness or clumping is immediate disqualification; authentic P21 reconstitutes uniformly with gentle swirling
  • HPLC purity
  • Single dominant peak at expected retention time, ≥98% purity
  • Multiple peaks, off-target retention time, or no detectable peptide signal
  • Third-party HPLC analysis (Colmaric, Janoshik)
  • HPLC separates authentic synthesis from fragment contamination or wrong compounds; <98% purity indicates synthesis failure
  • Mass spectrometry
  • Molecular weight 1682.95 Da ±0.5 Da
  • Mass >50 Da off target, or no peptide mass detected
  • Mass spec confirmation via independent lab
  • Confirms molecular identity; off-target mass means it's not P21 regardless of labeling
  • Endotoxin level
  • <1.0 EU/mg (pharmaceutical-grade threshold)
  • Often >10 EU/mg, indicating bacterial contamination
  • LAL assay (limulus amebocyte lysate test)
  • Endotoxin >1 EU/mg compromises research validity and signals non-sterile production environments
  • Batch traceability
  • CoA with batch number matching vial label, synthesis date, stability data
  • Generic CoA with no batch reference, or no CoA provided
  • Request batch-specific CoA before purchase
  • Batch traceability is mandatory for pharmaceutical-grade peptides; absence indicates unverified sourcing